Navigation Links
Longevinex(R) Files Lawsuit Against ResveratrolBenefits.com, for False and Misleading Statements
Date:9/9/2009

LAS VEGAS, Sept. 9 /PRNewswire/ -- Resveratrol Partners, LLC, makers of Longevinex(R), a leading resveratrol dietary supplement, today announced that it had filed suit in federal court in Los Angeles against "Jon Mayne," the alleged owner of the website ResveratrolBenefits.com.

The Complaint filed by Longevinex(R) alleges that Mayne's website, whose listed address and telephone number are those of a United Parcel Service storefront in San Francisco, has made false and misleading statements about Longevinex on its ResveratrolBenefits.com website, for the commercial benefit of purported competitors of Longevinex(R).

Mayne's ResveratrolBenefits.com website links directly to websites of companies making "free bottle offers" that have been the subject of thousands of complaints filed with Better Business Bureaus and are now believed to be under investigation by the Federal Trade Commission. These "free bottle offers" result in consumers' credit cards being charged for products that have not been specifically ordered.

The false and misleading statements made at the ResveratrolBenefits.com website include the following:

  • The posting of a price for Longevinex(R) that is more than twice the actual sales price of the product, making the product appear unduly overpriced.
  • The statement that Longevinex(R) is "less effective" than other products and "not truly effective," whereas Longevinex(R) in fact is the only resveratrol product whose efficacy has been established by human and animal studies and by scientific research.
  • The statement that "there are no truly free trials of Longevinex available," when "free trials" are meaningless for a product to be taken over a period of months and years, and when purported competitive products' "free trials" are in fact linked to deceptive over billing of customers' credit cards. <
    '/>"/>

SOURCE Resveratrol Partners, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New: Longevinex(R) First to Introduce Micronized Resveratrol Matrix - Now Stabilized by Microencapsulation
2. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
3. Researchers Report Combined Molecules in Red Wine by Far Exceed the Biological Activity of Plain Resveratrol, Consistent With the Composition of Longevinex(R)
4. Alvarado Hospital Files Countersuit Against Blue Shield
5. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
6. Pharsight Files Application for Nasdaq Capital Market Listing
7. Gentiva(R) Health Services Files Universal Shelf Registration Statement
8. Paramount Acquisition Corp. Files Amendment to Preliminary Proxy Statement for Proposed Acquisition of Chem Rx
9. CIGNA Behavioral Health Offers Members Online Provider Profiles
10. American Media Operations, Inc. Files Form 10-Q For First Quarter 2007
11. RxElite Files Registration Statement with Securities and Exchange Commission
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Mesothelioma Victims Center says, "According to the ... citizens, who will be diagnosed with a rare form ... will be US Navy Veterans. We can assure a ... of cancer, or their family members that we will ... mesothelioma compensation settlement attorneys, who actually do have a ...
(Date:6/19/2013)... Faith4Kidz is starting a new fundraising effrt ... would like help showing support for kids to learn how ... positive. Check out the website, http://www.gracenfaith.com to see ... red, white and blue stars as a symbol of our ... as well as the stars we should encourage our children ...
(Date:6/18/2013)... Exposed Skin Care has finally been released after much ... ages finally achieve the clear, beautiful skin they have always ... clearing system combines the power of science and nature to ... , After a quick review of Exposed ... the most effective available on the market to cure acne ...
(Date:6/18/2013)... South Africa (PRWEB) June 19, 2013 Looking ... disillusionment and monotony of everyday life? , IWALKAWAKE is ... awakening process. Written by Adam Botha, it focuses on harnessing ... , The book lays out a nine-step guide to ... a process that a person must go through to reach ...
(Date:6/18/2013)... York (PRWEB) June 19, 2013 The ... understanding and unprecedented access to the drug delivery partnering ... healthcare companies. , The report provides a detailed ... drug delivery partnering deals. The majority of deals are ... right or an option right to license the license ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4
... The Institute for Health Freedom (IHF) is warning the ... government to plan for each American to use "an" ... or patient-consent provisions."Congress needs to add opt-out and patient-consent ... IHF president. "The bottom line is that if YOU ...
... Full Value,Committee announced today that it has filed ... materials and is commencing,distribution of those soliciting materials ... ) ("LCAV") to solicit consents to replace the ... highly qualified nominees. The Full,Value Committee,s director ...
... 9 Team Health Inc.,s,parent company, Team Finance LLC ... fiscal year and the fourth quarter ended,December 31, 2008. ... for uncollectibles ("revenue less provision"),for the fiscal year ended ... billion in the prior year. Same contract revenue less ...
... Powerful opioid drugs can pose risks even for patients, ... The U.S. Food and Drug Administration announced plans Monday ... painkillers by requiring manufacturers of certain opioid drugs to ... with the medications. , The FDA said it has ...
... genes can be used to reliably identify the four ... at Washington University School of Medicine in St. Louis ... potentially predict the most effective therapy for each breast ... all patients., "Unlike a widely used genomic test that ...
... adolescent use of prescription pain relievers has dropped, report ... of prescription painkillers among young adults increased from 4.1 ... government report released Monday shows. , However, the researchers ... (SAMHSA) also found that non-medical use of painkillers by ...
Cached Medicine News:Health News:Economic Stimulus Bill Mandates Electronic Health Records for Every American by 2014 - With No Opt-out Provision 2Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 2Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 3Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 4Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 5Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 6Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 7Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 8Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 9Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 10Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 11Health News:The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders 12Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 2Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 3Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 4Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 5Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 6Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 7Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 8Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 9Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 10Health News:Team Finance LLC Announces Fiscal 2008 Financial Results 11Health News:FDA Seeks Better Regulation of Painkillers 2Health News:New genomic test can personalize breast cancer treatment 2Health News:New genomic test can personalize breast cancer treatment 3Health News:Painkiller Abuse Increases Among Young Adults 2
(Date:6/18/2013)... , June 18, 2013  Decision Resources, ... firms for pharmaceutical and healthcare issues, announces that ... of the Middle East ... Tracker analyzes the challenges and opportunities to gaining ... international regions comprising 24 countries. The countries covered ...
(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...
(Date:6/18/2013)... And EMERYVILLE, Calif. , June ... final results today from a Phase 2/3 clinical ... demonstrating a statistically significant improvement in levodopa-induced dyskinesia ... week 8 versus placebo in the Unified Dyskinesia ... formulation of amantadine intended for once-nightly administration that ...
Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6
... Therapeutics, Inc. (NASDAQ: ECTE ), a company ... wireless, transdermal continuous glucose monitoring system and its Prelude® ... Patrick T. Mooney, M.D., Chairman & CEO of Echo ... Conference. Dr. Mooney will make a presentation ...
... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... operating officer, is scheduled to present a company overview ... York City on Wednesday, December 14th at 1:00 p.m. ... ) To access the live audio webcast ...
Cached Medicine Technology:
Lacrimal Cannula, Curved - Open End, 21gSize: 21g x 1-1/2"....
PremierEdge™ Implant Knives....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: